Pfizer study tests drug interaction in healthy volunteers
NCT ID NCT07198035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the drug carbamazepine changes the way the body handles another drug called PF-07248144. Twelve healthy adults took PF-07248144 alone and then with carbamazepine. Researchers measured drug levels in the blood to understand the interaction and check for safety issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer Clinical Research Unit - Brussels
Brussels, Bruxelles-capitale, Région de, B-1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breakfast or fast? a trial puts Prifetrastat's absorption to the test
- Magic mushroom compound may rewire Self-Awareness — scientists put it to the test
- Can a phone app ease caregiver burnout? new study tests digital therapy
- Robotic hip brace may help control blood sugar after eating
- Smart knee brace and AI could revolutionize home rehab for arthritis
- Training the brain to hear and fix speech errors